| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A decreasing trend in fall-related hip fracture incidence in Victoria, Australia
|
Cassell, E.
|
|
2012
|
24 |
1 |
p. 99-109
|
artikel
|
| 2 |
A meta-analysis characterizing the dose–response relationships for three oral nitrogen-containing bisphosphonates in postmenopausal women
|
Yates, J.
|
|
2012
|
24 |
1 |
p. 253-262
|
artikel
|
| 3 |
Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study
|
Bondo, L.
|
|
2012
|
24 |
1 |
p. 245-252
|
artikel
|
| 4 |
Are long-term bisphosphonate users a reality? Dose years for current bisphosphonate users assessed using the danish national prescription database
|
Abrahamsen, B.
|
|
2012
|
24 |
1 |
p. 369-372
|
artikel
|
| 5 |
Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients
|
Pilz, S.
|
|
2012
|
24 |
1 |
p. 377-381
|
artikel
|
| 6 |
Balloon kyphoplasty compared to vertebroplasty and nonsurgical management in patients hospitalised with acute osteoporotic vertebral compression fracture: a UK cost-effectiveness analysis
|
Svedbom, A.
|
|
2012
|
24 |
1 |
p. 355-367
|
artikel
|
| 7 |
Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study
|
Kang, J.-H.
|
|
2012
|
24 |
1 |
p. 271-277
|
artikel
|
| 8 |
Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies
|
Sun, K.
|
|
2012
|
24 |
1 |
p. 279-286
|
artikel
|
| 9 |
Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study
|
Abrahamsen, B.
|
|
2012
|
24 |
1 |
p. 321-328
|
artikel
|
| 10 |
Comment on Kanis et al.: Pitfalls in the external validation of FRAX
|
Bolland, M. J.
|
|
2012
|
24 |
1 |
p. 389-390
|
artikel
|
| 11 |
Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight
|
Schousboe, J. T.
|
|
2012
|
24 |
1 |
p. 163-177
|
artikel
|
| 12 |
Cost-effectiveness of nutritional intervention in elderly subjects after hip fracture. A randomized controlled trial
|
Wyers, C. E.
|
|
2012
|
24 |
1 |
p. 151-162
|
artikel
|
| 13 |
Dairy foods and osteoporosis: an example of assessing the health-economic impact of food products
|
Lötters, F. J. B.
|
|
2012
|
24 |
1 |
p. 139-150
|
artikel
|
| 14 |
Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges
|
Solomon, D. H.
|
|
2012
|
24 |
1 |
p. 237-244
|
artikel
|
| 15 |
Depressive symptoms and rates of bone loss at the hip in older men
|
Diem, S. J.
|
|
2012
|
24 |
1 |
p. 111-119
|
artikel
|
| 16 |
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
|
McClung, M. R.
|
|
2012
|
24 |
1 |
p. 227-235
|
artikel
|
| 17 |
Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia—a randomized placebo-controlled trial
|
Chapurlat, R. D.
|
|
2012
|
24 |
1 |
p. 311-320
|
artikel
|
| 18 |
Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
|
Shiraki, M.
|
|
2012
|
24 |
1 |
p. 219-226
|
artikel
|
| 19 |
Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients
|
Gamsjaeger, S.
|
|
2012
|
24 |
1 |
p. 339-347
|
artikel
|
| 20 |
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
|
McClung, M. R.
|
|
2012
|
24 |
1 |
p. 293-299
|
artikel
|
| 21 |
Erratum to: Life-course evidence of birth weight effects on bone mass: systematic review and meta-analysis
|
Martínez-Mesa, J.
|
|
2012
|
24 |
1 |
p. 19-21
|
artikel
|
| 22 |
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
|
Kanis, J. A.
|
|
2012
|
24 |
1 |
p. 23-57
|
artikel
|
| 23 |
Life-course evidence of birth weight effects on bone mass: systematic review and meta-analysis
|
Martínez-Mesa, J.
|
|
2012
|
24 |
1 |
p. 7-18
|
artikel
|
| 24 |
Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)
|
Ioannidis, G.
|
|
2012
|
24 |
1 |
p. 59-67
|
artikel
|
| 25 |
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice
|
Thomas, T.
|
|
2012
|
24 |
1 |
p. 263-269
|
artikel
|
| 26 |
Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women
|
Tanaka, S.
|
|
2012
|
24 |
1 |
p. 69-76
|
artikel
|
| 27 |
Pitfalls in the external validation of FRAX: response to Bolland et al.
|
Kanis, J. A.
|
|
2012
|
24 |
1 |
p. 391-392
|
artikel
|
| 28 |
Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study
|
Bhattoa, H. P.
|
|
2012
|
24 |
1 |
p. 179-186
|
artikel
|
| 29 |
QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis
|
Lee, J. K.
|
|
2012
|
24 |
1 |
p. 287-292
|
artikel
|
| 30 |
Relationship between use of antidepressants and risk of fractures: a meta-analysis
|
Rabenda, V.
|
|
2012
|
24 |
1 |
p. 121-137
|
artikel
|
| 31 |
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
|
Freemantle, N.
|
|
2012
|
24 |
1 |
p. 209-217
|
artikel
|
| 32 |
Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men
|
Verschueren, S.
|
|
2012
|
24 |
1 |
p. 87-98
|
artikel
|
| 33 |
Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: results from the HORIZON Pivotal Fracture Trial
|
Yang, L.
|
|
2012
|
24 |
1 |
p. 329-338
|
artikel
|
| 34 |
Ten-year hip fracture incidence rate trends in a large California population, 1997–2006
|
Adams, A. L.
|
|
2012
|
24 |
1 |
p. 373-376
|
artikel
|
| 35 |
The cyclooxygenase-2 selective inhibitor NS-398 does not influence trabecular or cortical bone gain resulting from repeated mechanical loading in female mice
|
Sugiyama, T.
|
|
2012
|
24 |
1 |
p. 383-388
|
artikel
|
| 36 |
The effect of treatments for osteoporosis on mortality
|
Grey, A.
|
|
2012
|
24 |
1 |
p. 1-6
|
artikel
|
| 37 |
The impact of dietary calcium intake and vitamin D status on the effects of zoledronate
|
Bourke, S.
|
|
2012
|
24 |
1 |
p. 349-354
|
artikel
|
| 38 |
Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study
|
Boutroy, S.
|
|
2012
|
24 |
1 |
p. 77-85
|
artikel
|
| 39 |
Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
|
McClung, M. R.
|
|
2012
|
24 |
1 |
p. 301-310
|
artikel
|
| 40 |
Vitamin D2 from light-exposed edible mushrooms is safe, bioavailable and effectively supports bone growth in rats
|
Calvo, M. S.
|
|
2012
|
24 |
1 |
p. 197-207
|
artikel
|
| 41 |
Vitamin D status is associated with physical performance: the results of three independent cohorts
|
Sohl, E.
|
|
2012
|
24 |
1 |
p. 187-196
|
artikel
|
Tijdschrift beschrijving